Back
Myriad Genetics Stock Price Chart
Forget Bitcoin - This Is the Real Opportunity of 2024
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
MYGN
Myriad Genetics
Last Price:
26.45
Seasonality Move:
9.99%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYGN is experiencing selling pressure, which indicates risk of future bearish movement.
Myriad Genetics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.64 | Sell |
| 20-day SMA: | 27.1 | Sell |
| 50-day SMA: | 27.35 | Sell |
| 200-day SMA: | 23.47 | Buy |
| 8-day EMA: | 26.76 | Sell |
| 20-day EMA: | 27.01 | Sell |
| 50-day EMA: | 26.88 | Sell |
| 200-day EMA: | 24.08 | Buy |
Myriad Genetics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 44.92 | Sell |
| Chaikin Money Flow: | -223397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.3 - 27.92) | Sell |
| Bollinger Bands (100): | (24.05 - 27.85) | Buy |
Myriad Genetics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Myriad Genetics Stock
Is Myriad Genetics Stock a Buy?
- Myriad Genetics share price is 26.47 while MYGN 8-day simple moving average is 26.64, which is a Sell signal.
- The stock price of MYGN is 26.47 while Myriad Genetics 20-day SMA is 27.10, which makes it a Sell.
- Myriad Genetics 50-day simple moving average is 27.35 while MYGN share price is 26.47, making it a Sell technically.
- MYGN stock price is 26.47 and Myriad Genetics 200-day simple moving average is 23.47, creating a Buy signal.
MYGN Technical Analysis vs Fundamental Analysis
Sell
50
Myriad Genetics (MYGN)
is a Sell
Is Myriad Genetics a Buy or a Sell?
-
Myriad Genetics stock is rated a Sell
The current Myriad Genetics [MYGN] share price is $26.47. The Score for MYGN is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Myriad Genetics Stock Info
Market Cap:
2.4B
Price in USD:
26.47
Share Volume:
402.12K
Myriad Genetics 52-Week Range
52-Week High:
29.30
52-Week Low:
13.82
Sell
50
Myriad Genetics (MYGN)
is a Sell
Myriad Genetics Share Price Forecast
-
What is the Myriad Genetics stock price today?
The Myriad Genetics stock price is 26.47 USD today. -
Will MYGN stock go up or go down?
Myriad Genetics> share price is forecast to RISE/FALL based on technical indicators -
Is Myriad Genetics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Myriad Genetics is overvalued.
Is Myriad Genetics Stock a Buy?
- Myriad Genetics share price is 26.47 while MYGN 8-day exponential moving average is 26.76, which is a Sell signal.
- The stock price of MYGN is 26.47 while Myriad Genetics 20-day EMA is 27.01, which makes it a Sell.
- Myriad Genetics 50-day exponential moving average is 26.88 while MYGN share price is 26.47, making it a Sell technically.
- MYGN stock price is 26.47 and Myriad Genetics 200-day simple moving average is 24.08, creating a Buy signal.
Fundamental Analysis of Myriad Genetics
Is Myriad Genetics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.18 per share.
Technical Analysis of Myriad Genetics
Should I short Myriad Genetics stock?
- MYGN Moving Average Covergence Divergence (MACD) indicator is -0.19, suggesting Myriad Genetics is a Sell
- Myriad Genetics Relative Strength Index (RSI) is 44.92, which suggest Myriad Genetics is oversold
- The Bollinger Bands (25) for Myriad Genetics is (26.3 - 27.92), which suggest Myriad Genetics is a Buy
- The Bollinger Bands (100) for Myriad Genetics is (24.05 - 27.85), which suggest Myriad Genetics is a Buy
* Myriad Genetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.